How often do oncologists receive industry payments from competing companies?

ABSTRACT:

Background

Payments from pharmaceutical companies to oncologists can influence prescribing practices. However, some physicians believe that receiving payments from multiple competing manufacturers might balance these biasing effects, effectively "canceling out" any conflict of interest. This study examines how often physicians receive industry payments for multiple, competing drugs.

Methods

Using the CMS Part D Prescribers file 2017-2019, we included medical oncologists who prescribed a class of cancer drugs wherein there are multiple, competing drugs. We then matched these oncologists to their industry payments records (Open Payments). We assessed the proportion of oncologists who received any industry payments related to 0, 1, 2, or 3 of the competing drugs, and whether on

SUBMITTER: Keetley HM 

PROVIDER: S-EPMC12875597 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature